Insulin-induced retinal ganglion cell dendrite regeneration: characterization and identification of novel molecular mechanisms

Links

Summary

This study examines whether reducing intraocular pressure alone is sufficient to regenerate RGC dendrites in glaucoma, and identifies molecular pathways activated by insulin that drive this regeneration. For lighting and vision health contexts, the findings underscore that structural retinal damage in glaucoma requires active intervention beyond pressure management, with implications for understanding how photoreceptive cells (including ipRGCs) might be preserved or restored.

Key Findings

Brinzolamide effectively reduced intraocular pressure, but this reduction alone was insufficient to promote RGC dendrite regeneration in glaucomatous mice, suggesting exogenous insulin plays a role beyond endogenous signaling.
RNA sequencing of FACS-isolated RGCs identified multiple candidate signaling pathways activated by insulin treatment, including mTOR, Notch, glycolysis, fatty acid metabolism, DNA repair, and Myc targets.
Results support exogenous insulin administration as a therapeutic approach to restore retinal connectivity and function, and identify novel gene targets for glaucoma treatment.